Modernizing the Human Subjects Regulations
Given its importance in scientific development, human subjects research requires close regulatory attention.
Philip Rubin is the Chief Executive Officer emeritus of Haskins Laboratories and an adjunct professor at the Yale University School of Medicine. He was a science advisor at OSTP and led the White House neuroscience initiative during the Obama administration, and he co-chaired the NSTC Committee on Science and interagency Common Rule Modernization Working Group.
Given its importance in scientific development, human subjects research requires close regulatory attention.